Cdk5: multitasking between physiological and pathological conditions (Q24299163)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21473899%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

review article

1 reference

title

Cdk5: multitasking between physiological and pathological conditions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21473899%20AND%20SRC:MED&resulttype=core&format=json

cyclin dependent kinase 5

27 January 2020

main subject

1 reference

positive regulation of actin cytoskeleton reorganization

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author

João P Lopes

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21473899%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Paula M. Agostinho

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21473899%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Joao P Lopes

series ordinal

1

0 references

language of work or name

English

0 references

publication date

5 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21473899%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

published in

Progress in Neurobiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21473899%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21473899%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21473899%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

49-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21473899%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

The roles of cyclin-dependent kinase 5 in dendrite and synapse development

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Neuroprotective functions of prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Sequential expression of cell-cycle regulators and Alzheimer's disease-related proteins in entorhinal cortex after hippocampal excitotoxic damage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Regulation of membrane association and kinase activity of Cdk5-p35 by phosphorylation of p35.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Swedish amyloid precursor protein mutation increases cell cycle-related proteins in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

A novel disruption of cortical development in p35(-/-) mice distinct from reeler.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Callosal axon guidance defects in p35(-/-) mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Prion protein fragment 106-126 induces apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in the GH3 cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cyclin-dependent kinase-5/p35 phosphorylates Presenilin 1 to regulate carboxy-terminal fragment stability.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

1 reference

7 January 2021

Role of calcium in the pathogenesis of Alzheimer's disease and transgenic models.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Functions and malfunctions of the tau proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

p35nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

An unusual member of the Cdk family: Cdk5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Estradiol attenuates tau hyperphosphorylation induced by upregulation of protein kinase-A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Calpains and delayed calcium deregulation in excitotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

The role of the prion protein in the molecular basis for synaptic plasticity and nervous system development

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Regulation of calpain-2 in neurons: implications for synaptic plasticity

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Evidence for amylase release by cyclin-dependent kinase 5 in the rat parotid.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Tau pathology in Alzheimer disease and other tauopathies

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Neuronal cell cycle re-entry mediates Alzheimer disease-type changes

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Alzheimer disease: amyloidogenesis, the presenilins and animal models.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Recent advances in understanding the roles of Cdk5 in synaptic plasticity

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

High content analysis of gamma-secretase activity reveals variable dominance of presenilin mutations linked to familial Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cdk5, a therapeutic target for Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Susceptibility of hippocampal neurons to Abeta peptide toxicity is associated with perturbation of Ca2+ homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Contribution of calpain activation to early stages of hippocampal damage during oxygen-glucose deprivation

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Different fibrillar Abeta 1-42 concentrations induce adult hippocampal neurons to reenter various phases of the cell cycle.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Molecular targets in cerebral ischemia for developing novel therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Molecular mechanisms of dendritic spine morphogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cyclin-dependent kinase-5 targeting for ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cell-cycle regulators are involved in transient cerebral ischemia induced neuronal apoptosis in female rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Regulation of phosphorylation of tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

PKA modulates GSK-3beta- and cdk5-catalyzed phosphorylation of tau in site- and kinase-specific manners

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Scrapie-infected GT1-1 cells show impaired function of voltage-gated N-type calcium channels (Ca(v) 2.2) which is ameliorated by quinacrine treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Abeta inhibits the proteasome and enhances amyloid and tau accumulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Synaptic roles of Cdk5: implications in higher cognitive functions and neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

CDK5 serves as a major control point in neurotransmitter release.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Calpain inhibition prevents amyloid-beta-induced neurodegeneration and associated behavioral dysfunction in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cyclin-dependent kinase 5-dependent phosphorylation of Pctaire1 regulates dendrite development

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Pathogenesis of nigral cell death in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Activation of the calpain/cdk5/p25 pathway in the girus cinguli in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

The cell cycle as a therapeutic target for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

The role of amyloid beta peptide 42 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Making a neuron: Cdk5 in embryonic and adult neurogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

α-Synuclein and dopamine at the crossroads of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

1 reference

7 January 2021

Amyloid, the presenilins and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cyclin dependent kinase-5 (CDK-5) phosphorylates neurofilament heavy (NF-H) chain to generate epitopes for antibodies that label neurofilament accumulations in amyotrophic lateral sclerosis (ALS) and is present in affected motor neurones in ALS

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Copper and prion disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

From Charcot to SOD1: mechanisms of selective motor neuron death in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cell cycle activation linked to neuronal cell death initiated by DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

1 reference

7 January 2021

Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Proteolytic fragments of the Alzheimer's disease associated presenilins-1 and -2 are phosphorylated in vivo by distinct cellular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Neurotoxicity induces cleavage of p35 to p25 by calpain

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Mitotic kinases as regulators of cell division and its checkpoints

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

1 reference

7 January 2021

Formation of beta-amyloid protein deposits in brains of transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Erratum: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

A suspicious signature

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

1 reference

7 January 2021

Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Mechanisms, challenges and opportunities in stroke

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

PDZ domain proteins of synapses

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Pathogenesis of prion diseases: a progress report

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cycling at the interface between neurodevelopment and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Normal prion protein has an activity like that of superoxide dismutase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

From tau phosphorylation to tau aggregation: what about neuronal death?

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Involvement of calcineurin in the neurotoxic effects induced by amyloid-beta and prion peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Improved reversal learning and altered fear conditioning in transgenic mice with regionally restricted p25 expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Proteasomal degradation of tau protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cellular prion protein function in copper homeostasis and redox signalling at the synapse

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Physiological role of the cellular prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Association between early-onset Parkinson's disease and mutations in the parkin gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Perinatal abrogation of Cdk5 expression in brain results in neuronal migration defects

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Phosphorylation of spinophilin by ERK and cyclin-dependent PK 5 (Cdk5).

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Aberrant motor axon projection, acetylcholine receptor clustering, and neurotransmission in cyclin-dependent kinase 5 null mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Regulation of NMDA receptors by cyclin-dependent kinase-5

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Evidence for phosphorylation and oligomeric assembly of presenilin 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

1 reference

7 January 2021

Spinophilin regulates the formation and function of dendritic spines

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Channel formation by a neurotoxic prion protein fragment

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Regulation of Munc-18/syntaxin 1A interaction by cyclin-dependent kinase 5 in nerve endings

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Amphiphysin 1 binds the cyclin-dependent kinase (cdk) 5 regulatory subunit p35 and is phosphorylated by cdk5 and cdc2

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Glycogen synthase kinase-3beta regulates presenilin 1 C-terminal fragment levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Proteomic analysis of in vivo phosphorylated synaptic proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

The beta-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Amyloid precursor protein trafficking, processing, and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

APP processing is regulated by cytoplasmic phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cophosphorylation of amphiphysin I and dynamin I by Cdk5 regulates clathrin-mediated endocytosis of synaptic vesicles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Tau phosphorylation sites work in concert to promote neurotoxicity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Neurabin-I is phosphorylated by Cdk5: implications for neuronal morphogenesis and cortical migration.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Nestin as a regulator of Cdk5 in differentiating myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Mitotic signaling by beta-amyloid causes neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Synaptic localization of p39, a neuronal activator of cdk5

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Pathology and biology of the Lewy body

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Immunohistochemical expression of prion protein (PrPC) in the human forebrain during development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Immunotherapeutic effect of anti-PrP monoclonal antibodies in transmissible spongiform encephalopathy mouse models: pharmacokinetic and pharmacodynamic analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Neuregulin induces GABAA receptor beta2 subunit expression in cultured rat cerebellar granule neurons by activating multiple signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Impairment of hippocampal long-term depression and defective spatial learning and memory in p35 mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Activation of latent cyclin-dependent kinase 5 (Cdk5)-p35 complexes by membrane dissociation

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cyclin-dependent kinase 5 in synaptic plasticity, learning and memory.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Temporal correlation of the memory deficit with Alzheimer-like lesions induced by activation of glycogen synthase kinase-3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

AAV-mediated expression of wild-type and ALS-linked mutant VAPB selectively triggers death of motoneurons through a Ca2+-dependent ER-associated pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Regulation and role of cyclin-dependent kinase activity in neuronal survival and death

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Neurodegeneration in an Aβ-induced model of Alzheimer’s disease: the role of Cdk5

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

The ubiquitin-proteasome system in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cell proliferation and cell cycle control: a mini review

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Expression of cyclin-dependent kinase 5 mRNA and protein in the human brain following acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

A portrait of Alzheimer secretases--new features and familiar faces

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Signal transduction through prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Calpain in the CNS: from synaptic function to neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cyclin-dependent kinases: engines, clocks, and microprocessors

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

The prion's elusive reason for being

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Balancing structure and function at hippocampal dendritic spines

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Copper and the prion protein: methods, structures, function, and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

The public health impact of prion diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Properties of cytotoxic peptide-formed ion channels

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cyclin-dependent kinase 5 in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Ca2+ signals and neuronal death in brain ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Alzheimer disease therapy: can the amyloid cascade be halted?

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Changes of tau profiles in brains of the hamsters infected with scrapie strains 263 K or 139 A possibly associated with the alteration of phosphate kinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

HDAC-3 participates in the repression of e2f-dependent gene transcription in primary differentiated neurons

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Prion protein aggregation and neurotoxicity in cortical neurons

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cyclin-dependent kinase 5 regulates steroidogenic acute regulatory protein and androgen production in mouse Leydig cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Transmitting on actin: synaptic control of dendritic architecture

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

The role of CDK5/P25 formation/inhibition in neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cdk5 regulates accurate maturation of newborn granule cells in the adult hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Regulation of hippocampal and behavioral excitability by cyclin-dependent kinase 5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Calpain and synaptic function

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Memory impairment in transgenic Alzheimer mice requires cellular prion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cyclin-dependent kinase 5 is required for control of neuroblast migration in the postnatal subventricular zone

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

RB and Cdc2 expression in brain: correlations with 3H-thymidine incorporation and neurogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cdk5 regulates the phosphorylation of tyrosine 1472 NR2B and the surface expression of NMDA receptors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Neuronal cyclin-dependent kinase 5 activity is critical for survival.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cyclin-dependent kinase 5 phosphorylates disabled 1 independently of Reelin signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Phosphorylation of prion protein at serine 43 induces prion protein conformational change

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Hypoxia-ischemia induces DNA synthesis without cell proliferation in dying neurons in adult rodent brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Essential role of cytoplasmic cdk5 and Prx2 in multiple ischemic injury models, in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Postsynaptic density 95 controls AMPA receptor incorporation during long-term potentiation and experience-driven synaptic plasticity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Treatment of Alzheimer's disease across the spectrum of severity

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Relevance of abeta1-42 intrahippocampal injection as an animal model of inflamed Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cell cycle re-entry in Alzheimer's disease: a major neuropathological characteristic?

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cyclin-dependent kinase 5 promotes pancreatic β-cell survival via Fak-Akt signaling pathways.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-beta and prion peptides.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

Cdk5, the multifunctional surveyor

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNEUROBIO.2011.03.006

7 January 2021

10.1016/J.PNEUROBIO.2011.03.006

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

3674504

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21473899%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

3674504

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

3674504